2m 2m 2m 2m 2m 2m 2m
PROGYNY (PGNY)
NASDAQ
$24.89-$0.23 (-0.93%)
Price as of Jun 03, 2026 5:46 PM EDT- $2.0BMarket Cap
- 14.29%1-Year Change
- Healthcare PlansIndustry
PROGYNY (PGNY)
$24.89-$0.23 (-0.93%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.3B +10.40% | 1.2B +7.22% | 1.1B +38.34% | 786.9M +170,596.96% | |
Cost of Revenue | 984.2M +7.69% | 913.9M +7.54% | 849.8M +37.16% | 619.6M +59.49% | |
Gross Profit | 304.5M +20.18% | 253.4M +6.10% | 238.8M +42.72% | 167.3M +49.22% | |
Sales and Marketing Expense | 72.1M +12.77% | 63.9M +7.50% | 59.5M +30.29% | 45.7M +126.26% | |
Research and Development Expense | -9.5M N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 4.9M +55.84% | 3.2M +39.19% | 2.3M +42.47% | 1.6M +23.06% | |
Total Operating Expenses | 219.2M +17.91% | 185.9M +5.26% | 176.6M +22.66% | 144.0M +80.44% | |
Operating Profit | 85.3M +26.42% | 67.5M +8.48% | 62.2M +166.42% | 23.3M -27.83% | |
Interest Income | 10.2M -35.51% | 15.7M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -38,000 0.00% | -38,000 0.00% | |
Interest Income and Expense and Net | 10.2M -35.51% | 15.7M +41,539.47% | -38,000 0.00% | -38,000 0.00% | |
Total Nonoperating Income and Expense | 10.2M -35.51% | 15.7M +85.11% | 8.5M +673.36% | 1.1M +1,057.89% | |
Income before Taxes | 95.4M +14.70% | 83.2M +17.70% | 70.7M +189.23% | 24.4M -24.65% | |
Income Taxes | 36.9M +27.87% | 28.9M +233.56% | 8.7M +246.26% | -5.9M -82.25% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 58.5M +7.70% | 54.3M -12.41% | 62.0M +104.35% | 30.4M -53.84% | |
Net Income from Continuing Operations Applicable to Common | 95.4M +14.70% | 83.2M +17.70% | 70.7M +189.23% | 24.4M -24.65% | |
Basic EPS and Net Income | 0.68 +15.25% | 0.59 -9.23% | 0.65 +96.97% | 0.33 -55.41% | |
Diluted EPS and Net Income | 0.65 +14.04% | 0.57 -8.06% | 0.62 +106.67% | 0.30 -54.55% | |
Basic Weighted Average Shares | 85.7M -6.37% | 91.5M -3.72% | 95.0M +3.07% | 92.2M +3.47% | |
Diluted Weighted Average Shares | 89.9M -5.85% | 95.4M -5.19% | 100.7M +0.72% | 100.0M -0.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 112.2M -30.85% | 162.3M +66.82% | 97.3M -18.97% | 120.1M +31.36% | |
Short-Term Investments | 197.9M +201.43% | 65.6M -76.03% | 273.8M +295.53% | 69.2M +147.18% | |
Cash and Cash Equivalents and Short-Term Investments | 310.1M +36.03% | 228.0M -38.57% | 371.1M +96.03% | 189.3M +58.52% | |
Total Current Assets | 551.8M +16.72% | 472.7M -26.18% | 640.4M +47.61% | 433.9M +67.81% | |
Accumulated Depreciation | 12.3M +47.51% | 8.4M +57.86% | 5.3M +69.96% | 3.1M +21.69% | |
Property and Plant and Equipment and Net | 29.9M +141.68% | 12.4M +21.25% | 10.2M +22.00% | 8.4M +66.52% | |
Total Long-Term Assets | 16.5M +455.46% | 3.0M -12.31% | 3.4M -14.87% | 4.0M +35.60% | |
Total Assets | 742.4M +22.29% | 607.1M -19.76% | 756.6M +39.34% | 543.0M +51.64% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 202.4M +20.02% | 168.6M -9.32% | 185.9M +16.56% | 159.5M +61.43% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 24.0M +46.23% | 16.4M -4.80% | 17.2M +165.98% | 6.5M +639.95% | |
Total Liabilities | 226.4M +22.35% | 185.0M -8.93% | 203.2M +22.39% | 166.0M +56.26% | |
Retained Earnings | 202.8M +40.55% | 144.3M +60.39% | 90.0M +222.08% | 27.9M +1,252.39% | |
Total Stockholders Equity | 516.0M +22.27% | 422.1M -23.74% | 553.4M +46.81% | 377.0M +49.70% | |
Total Shares Outstanding | 83.4M -2.28% | 85.3M -11.46% | 96.3M +3.27% | 93.3M +2.43% | |
Cash Flow | |||||
Cash from Operating Activities | 210.2M +17.36% | 179.1M -5.14% | 188.8M +134.86% | 80.4M +208.77% | |
Capital Expenditures | 18.4M +240.61% | 5.4M +48.33% | 3.6M +12.43% | 3.2M +52.23% | |
Cash from Investing Activities | -159.0M -181.22% | 195.8M +197.64% | -200.5M +357.13% | -43.9M -600.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -99.4M -67.94% | -309.9M +2,698.77% | -11.1M +40.79% | -7.9M -42.58% | |
Financials Ratio | |||||
Gross Margin | 23.63% +8.85% | 21.71% -1.05% | 21.94% +3.16% | 21.26% +100.03% | |
Operating Margin | 6.62% +14.51% | 5.78% +1.17% | 5.71% +92.59% | 2.97% -99.96% | |
Return on Assets | 8.67% +8.83% | 7.97% -16.53% | 9.55% +41.68% | 6.74% -68.65% | |
Return on Equity | 12.48% +11.99% | 11.14% -16.46% | 13.34% +38.11% | 9.66% -69.26% | |
Revenue Growth | 10.40% +44.05% | 7.22% -81.16% | 38.34% -99.98% | 170,596.96% +60,612.46% | |
Current Ratio | 2.73 -2.75% | 2.80 -18.60% | 3.44 +26.64% | 2.72 +3.95% | |
Cash Ratio | 0.55 -42.39% | 0.96 +83.98% | 0.52 -30.49% | 0.75 -18.63% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow